European Archives - Page 414 of 1146 - European Medical Journal

Aiming for Clinical Remission in Asthma: The Next Frontier

For many people living with asthma, medications such as inhaled corticosteroids (ICS) and short- or long-acting β agonists…

EMJ Reproductive Health 9 [Supplement 1] 2023

Unintended pregnancies have significant and potentially negative impacts on females and their families. Further, these pregnancies…

Spherical Ball-Shaped Intrauterine Device Long-Acting Reversible Contraception: Post-marketing Pharmacovigilance Assessment

Unintended pregnancies have significant and potentially negative impacts on females and their families. Further, these pregnancies…

“Did you know” Video Podcast Series

Moderated by Dr. Hannah Moir PhD: Senior Medical Writer and Moderator, EMJ. With speakers: Prof. Tommaso Simoncini, Prof. Andrea…

Filling the Gap by Targeting the Gut: First Disease-Modifying Treatment Approved for IgA Nephropathy

Bengt Fellström, Uppsala University, Sweden, described the relationship between IgA nephropathy (IgAN) and gastrointestinal mucosal…

Review of the 60th European Renal Association (ERA) Congress

CELEBRATING 60 years of congresses, the European Renal Association (ERA) held their 2023 congress in Milan, Italy, and virtually…

ERA 2023 Abstract Highlights

The following selected highlights explore several fascinating abstracts that were presented at the 60th European Renal…

EAN 2023: Cutting edge diagnosis and management strategies in neuromuscular disease.

EAN 2023: Cutting edge diagnosis and management strategies in neuromuscular disease. This highly informative and thought-provoking…

EMJ Nephrology 11.1 2023

We are delighted to share the latest issue of EMJ Nephrology with you, featuring peer-reviewed articles, as well as insightful interviews with esteemed experts in the field.

Proteinuria as a Surrogate Endpoint for Disease Progression in IgA Nephropathy: Predicting Long-Term Treatment Effects of Sparsentan

IgA nephropathy (IgAN) is a rare, life-limiting disease for which there is significant unmet need. Until recently, drug development for…